INTERNATIONAL PATENT: SHANGHAI XIANSAI BIOTECHNOLOGY CO., LTD., 上海先赛生物科技有限公司 FILES APPLICATION FOR "PROTEIN ANTIGEN COMBINATION FOR ACUTE MYOCARDIAL INFARCTION DETECTION AND USE THEREOF"

GENEVA, April 4 -- SHANGHAI XIANSAI BIOTECHNOLOGY CO., LTD. (Floor 1, No.4, Lane 215, Amber RoadPudong New Area, Shanghai 201321), 上海先赛生物科技有限公司 (中国上海市浦东新区琥珀路215弄4号1层) filed a patent application (PCT/CN2025/076594) for "PROTEIN ANTIGEN COMBINATION FOR ACUTE MYOCARDIAL INFARCTION DETECTION, AND USE THEREOF" on Feb 10, 2025. With publication no. WO/2026/065877, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed...